Results 1 to 10 of about 1,502,489 (240)
Micro/Nano Technologies for High-Density Retinal Implant [PDF]
Micromachines, 2019 During the past decades, there have been leaps in the development of micro/nano retinal implant technologies, which is one of the emerging applications in neural interfaces to restore vision. However, higher feedthroughs within a limited space are needed
Qi Zeng, Tianzhun Wu
exaly +5 more sources
Electronic retinal implant surgery. [PDF]
Eye (Lond), 2017 Blindness due to outer retinal degeneration still remains largely untreatable. Photoreceptor loss removes light sensitivity, but the remaining inner retinal layers, the optic nerve, and indeed the physical structure of the eye itself may be unaffected by the degenerative processes.
MacLaren RE.
europepmc +5 more sources
Chronic electrical stimulation with a peripheral suprachoroidal retinal implant: a preclinical safety study of neuroprotective stimulation [PDF]
Frontiers in Cell and Developmental BiologyPurposeExtraocular electrical stimulation is known to provide neuroprotection for retinal cells in retinal and optic nerve diseases. Currently, the treatment approach requires patients to set up extraocular electrodes and stimulate potentially weekly due
Chris E Williams +2 more
exaly +4 more sources
Widening use of dexamethasone implant for the treatment of macular edema [PDF]
Drug Design, Development and Therapy, 2017 Vincenza Bonfiglio, Michele Reibaldi, Matteo Fallico, Andrea Russo, Alessandra Pizzo, Stefano Fichera, Carlo Rapisarda, Iacopo Macchi, Teresio Avitabile, Antonio Longo Department of Ophthalmology, University of Catania, Catania, Italy Abstract: Sustained-
Bonfiglio V +9 more
doaj +4 more sources
Comparison between “early” or “late” intravitreal injection of dexamethasone implant in branch (BRVO) or central (CRVO) retinal vein occlusion: six-months follow-up [PDF]
Cutaneous and Ocular Toxicology, 2017 AIM: The aim of this study was to compare early and late injections of intravitreal dexamethasone implant in patients affected by central retinal vein occlusion (CRVO) or branch retinal vein occlusion (BRVO) with a six-months follow-up.
Fernanda Pacella +2 more
exaly +3 more sources
Frontiers in Neuroscience, 2017 Purpose: We assessed the safety and efficacy of a technically advanced subretinal electronic implant, RETINA IMPLANT Alpha AMS, in end stage retinal degeneration in an interim analysis of two ongoing prospective clinical trials.
Katarina Stingl +2 more
exaly +2 more sources
European Journal of Ophthalmology, 2018 Purpose: Dexamethasone intravitreal implant and intravitreal ranibizumab are indicated for the treatment of macular edema secondary to retinal vein occlusion.
Francesco Bandello +2 more
exaly +2 more sources
Therapeutic Advances in Ophthalmology, 2019 Introduction: Macular edema after central retinal vein occlusion is a common cause of vision loss. Upregulation of vascular endothelial growth factor and higher levels of inflammatory mediators have been involved in the pathogeny of the macular edema in ...
João Coelho +2 more
exaly +2 more sources